Covered recipient · General Payments record
CAMERON C DENGLER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$546.23
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.66 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $95.86 | 5 |
| Merck Sharp & Dohme Corporation | $48.15 | 2 |
| Janssen Biotech, Inc. | $41.32 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $38.45 | 2 |
| Regeneron Healthcare Solutions, Inc. | $19.92 | 1 |
| Ardelyx, Inc. | $19.77 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.30 | 1 |
| PFIZER INC. | $14.75 | 1 |
| QOL Medical, LLC | $14.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.29 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012009 | CMS |
| ABBVIE INC. | $19.13 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012011 | CMS |
| ABBVIE INC. | $27.86 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012013 | CMS |
| ABBVIE INC. | $13.81 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012015 | CMS |
| ABBVIE INC. | $13.77 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012017 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.25 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147021103 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.20 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146959875 | CMS |
| Ardelyx, Inc. | $19.77 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146724180 | CMS |
| Janssen Biotech, Inc. | $23.06 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078330753 | CMS |
| Janssen Biotech, Inc. | $18.26 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078331420 | CMS |
| Merck Sharp & Dohme LLC | $25.03 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141628893 | CMS |
| Merck Sharp & Dohme LLC | $23.12 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141847781 | CMS |
| PFIZER INC. | $14.75 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131437997 | CMS |
| QOL Medical, LLC | $14.14 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147734930 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.92 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114292229 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.30 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137733850 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.